Company intelligence / Profile preview

StairMed

Shanghai, Shanghai, Chinastairmed.com ↗

Ownership: Private
Development stage: Preclinical

Overview

StairMed has developed China's first high-throughput implantable BCI system meeting medical device standards. The company has demonstrated clinical effectiveness through more than fifty IITs with leading hospitals, established the world’s largest flexible electrode single-cell dataset from human studies, and plans to launch China’s first prospective FIM trial of long-term implantable BCIs in humans by mid-decade.

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceImplantable brain-computer interface systemNeural electrode array (flexible micro-nano electrodes)
Industry: Implantable Medical Devices

Partnerships

Collaborations with leading hospitals across China for clinical research/trialsMember of Brain–Computer Interface Industry AllianceShanghai Industrial Technology Innovation Promotion Association

Beyond the preview

Go deeper on StairMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StairMed.

Explore the full profile